HDACi - Targets beyond chromatin

被引：127

作者：

Buchwald, Marc ^{[1
]}

Kraemer, Oliver H. ^{[1
]}

Heinzel, Thorsten ^{[1
]}

机构：

[1] Univ Jena, CMB, Inst Biochem & Biophys, D-07745 Jena, Germany

来源：

CANCER LETTERS | 2009年 / 280卷 / 02期

关键词：

Acetylation; Proteasomal degradation; STATs; NF-kappaB; Signaling crosstalk; NF-KAPPA-B; HISTONE-DEACETYLASE INHIBITORS; NECROSIS-FACTOR-ALPHA; PROTEASOME INHIBITOR; PROTEIN-KINASE; VALPROIC ACID; CANCER-CELLS; IFN-GAMMA; TRANSCRIPTIONAL ACTIVATION; STIMULATED TRANSCRIPTION;

D O I：

10.1016/j.canlet.2009.02.028

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Histone deacetylases (HDACs) play an important role in gene regulation. Inhibitors of HDACs (HDACi) are novel anti-cancer drugs, which induce histone (hyper-) acetylation and Counteract aberrant gene repression. On the other hand, HDACi treatment can also result in decreased gene expression, and targeting HDACs affects more than chromatin. Recently, HDACi were shown to evoke non-histone protein acetylation, which can alter signaling networks relevant for tumorgenesis. Furthermore, HDACi can promote the degradation of (proto-) oncoproteins. Here, we summarize these findings and discuss how these substances could be beneficial for the treatment and prevention of human ailments, such as cancer and unbalanced immune functions. (C) 2009 Elsevier Ireland Ltd. All rights reserved.

引用

页码：160 / 167

页数：8

共 87 条

[21] Mechanisms of Disease: insights into the emerging role of signal transducers and activators of transcription in cancer [J].

Haura, EB ;

Turkson, J ;

Jove, R .

NATURE CLINICAL PRACTICE ONCOLOGY, 2005, 2 (06) :315-324

[22] IFN-γ protects cerulein-induced acute pancreatitis by repressing NF-κB activation [J].

Hayashi, Takahito ;

Ishida, Yuko ;

Kimura, Akihiko ;

Iwakura, Yoichiro ;

Mukaida, Naofumi ;

Kondo, Toshikazu .

JOURNAL OF IMMUNOLOGY, 2007, 178 (11) :7385-7394

[23] Synergistic interaction of the histone deacetylase inhibitor SAHA with the proteasome inhibitor bortezomib in mantle cell lymphoma [J].

Heider, Ulrike ;

von Metzler, Ivana ;

Kaiser, Martin ;

Rosche, Marleen ;

Sterz, Jan ;

Roetzer, Susanne ;

Rademacher, Jessica ;

Jakob, Christian ;

Fleissner, Claudia ;

Kuckelkorn, Ulrike ;

Kloetzel, Peter-Michael ;

Sezer, Orhan .

EUROPEAN JOURNAL OF HAEMATOLOGY, 2008, 80 (02) :133-142

[24]

Heinzel T., 2007, DRUG DISCOV TODAY DI, V4, P277

[25] The transcriptional coactivator CREB-binding protein cooperates with STAT1 and NF-κB for synergistic transcriptional activation of the CXC ligand 9/monokine induced by interferon-γ gene [J].

Hiroi, M ;

Ohmori, Y .

JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (01) :651-660

[26] The role of IL-6 and STAT3 in inflammation and cancer [J].

Hodge, DR ;

Hurt, EM ;

Farrar, WL .

EUROPEAN JOURNAL OF CANCER, 2005, 41 (16) :2502-2512

[27] Regulation and destabilization of HIF-1α by ARD1-mediated acetylation [J].

Jeong, JW ;

Bae, MK ;

Ahn, MY ;

Kim, SH ;

Sohn, TK ;

Bae, MH ;

Yoo, MA ;

Song, EJ ;

Lee, KJ ;

Kim, KW .

CELL, 2002, 111 (05) :709-720

[28] Histone-deacetylase inhibitors: Novel drugs for the treatment of cancer [J].

Johnstone, RW .

NATURE REVIEWS DRUG DISCOVERY, 2002, 1 (04) :287-299

[29] NFκB:: Linking inflammation and immunity to cancer development and progression [J].

Karin, M ;

Greten, FR .

NATURE REVIEWS IMMUNOLOGY, 2005, 5 (10) :749-759

[30] Post-activation turn-off of NF-κB-dependent transcription is regulated by acetylation of p65 [J].

Kiernan, R ;

Brès, V ;

Ng, RWM ;

Coudart, MP ;

El Messaoudi, S ;

Sardet, C ;

Jin, DY ;

Emiliani, S ;

Benkirane, M .

JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (04) :2758-2766

← 1 2 3 4 5 6 7 8 9 →